| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences,*and the Model Animal Genetics Research Center,Nanjing University, Nanjing, China
Recent reports suggested that phosphatase of regenerating liver (PRL)-3 might be involved in colorectal carcinoma metastasis with an unknown mechanism. Here we demonstrated that PRL-3 expression was up-regulated in human liver carcinoma compared with normal liver. PRL-3 was also highly expressed in metastatic melanoma B16-BL6 cells but not in its lowly metastatic parental cell line, B16 cells. B16 cells transfected with PRL-3 cDNA displayed morphological transformation from epithelial-like shape to fibroblast-like shape. PRL-3-overexpressed cells showed much higher migratory ability, which could be reversed by specific anti-sense oligodeoxynucleotide and the phosphatase inhibitors sodium orthovanadate or potassium bisperoxo oxovanadate V. Meanwhile, the expression of the catalytically inactive PRL-3 mutations (D72A or C104S) significantly reduced the cell migratory capability. In addition, PRL-3 transfectants demonstrated altered extracellular matrix adhesive property and up-regulated integrin-mediated cell spreading efficiency. Furthermore, we confirmed that PRL-3 could facilitate lung and liver metastasis of B16 cells in an experimental metastasis model in mice, consistent with accelerated proliferation and growth rate both in vitro and in vivo. Together, these observations provide convincing evidence that PRL-3 truly plays a causal role in tumor metastasis.
This article has been cited by other articles:
 |
|
 |
|
  L. Wang, Y. Shen, R. Song, Y. Sun, J. Xu, and Q. Xu An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells Mol. Pharmacol., December 1, 2009; 76(6): 1238 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. GUZINSKA-USTYMOWICZ, A. PRYCZYNICZ, and A. KEMONA PTP4A3 Expression Increases Strongly in Lymph Node Metastases from Colorectal Carcinoma Anticancer Res, October 1, 2009; 29(10): 3913 - 3916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Liang, Y. Luo, Y. Dong, C. D. Walls, J. Liang, H.-Y. Jiang, J. R. Sanford, R. C. Wek, and Z.-Y. Zhang Translational Control of C-terminal Src Kinase (Csk) Expression by PRL3 Phosphatase J. Biol. Chem., April 18, 2008; 283(16): 10339 - 10346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Daouti, W.-h. Li, H. Qian, K.-S. Huang, J. Holmgren, W. Levin, L. Reik, D. L. McGady, P. Gillespie, A. Perrotta, et al. A Selective Phosphatase of Regenerating Liver Phosphatase Inhibitor Suppresses Tumor Cell Anchorage-Independent Growth by a Novel Mechanism Involving p130Cas Cleavage Cancer Res., February 15, 2008; 68(4): 1162 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.-M. Fagerli, R. U. Holt, T. Holien, T. K. Vaatsveen, F. Zhan, K. W. Egeberg, B. Barlogie, A. Waage, H. Aarset, H. Y. Dai, et al. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells Blood, January 15, 2008; 111(2): 806 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Stephens, H. Han, G. Hostetter, M. J. Demeure, and D. D. Von Hoff Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells Mol. Cancer Ther., January 1, 2008; 7(1): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Liang, J. Liang, W.-Q. Wang, J.-P. Sun, E. Udho, and Z.-Y. Zhang PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation J. Biol. Chem., February 23, 2007; 282(8): 5413 - 5419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Dumaual, G. E. Sandusky, P. L. Crowell, and S. K. Randall Cellular Localization of PRL-1 and PRL-2 Gene Expression in Normal Adult Human Tissues J. Histochem. Cytochem., December 1, 2006; 54(12): 1401 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Guo, J. Li, H. Wang, M. Osato, J. P. Tang, S. Y. Quah, B. Q. Gan, and Q. Zeng PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo Cancer Res., October 1, 2006; 66(19): 9625 - 9635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Wang, L Peng, B Dong, L Kong, L Meng, L Yan, Y Xie, and C Shou Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome Ann. Onc., October 1, 2006; 17(10): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Fiordalisi, P. J. Keller, and A. D. Cox PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res., March 15, 2006; 66(6): 3153 - 3161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rouleau, A. Roy, T. St. Martin, M. R. Dufault, P. Boutin, D. Liu, M. Zhang, K. Puorro-Radzwill, L. Rulli, D. Reczek, et al. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol. Cancer Ther., February 1, 2006; 5(2): 219 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Stephens, H. Han, V. Gokhale, and D. D. Von Hoff PRL phosphatases as potential molecular targets in cancer Mol. Cancer Ther., November 1, 2005; 4(11): 1653 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, K. Guo, V. W. C. Koh, J. P. Tang, B. Q. Gan, H. Shi, H. X. Li, and Q. Zeng Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases Clin. Cancer Res., March 15, 2005; 11(6): 2195 - 2204. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
